Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of anakinra and tocilizumab in management of severe COVID-19: a retrospective cohort study.
Küçükşahin O, Erden A, Karakaş Ö, Güven SC, Armağan B, Şahiner EŞ, İnan O, Kurtipek AC, Gemcioğlu E, Karaahmetoğlu S, Turan S, İzdeş S, Erdem D, Aypak A, Ayhan M, Akıncı E, Bodur H, Güner R, Omma A, Ateş İ. Küçükşahin O, et al. Among authors: aypak a. Turk J Med Sci. 2022 Oct;52(5):1486-1494. doi: 10.55730/1300-0144.5487. Epub 2022 Oct 19. Turk J Med Sci. 2022. PMID: 36422492 Free PMC article.
COVID-19 experience of the major pandemic response center in the capital: results of the pandemic’s first month in Turkey.
Güner R, Hasanoğlu İ, Kayaaslan B, Aypak A, Kaya Kalem A, Eser F, Özdemir B, Sarıcaoğlu EM, Ayhan M, Aybar Bilir Y, Özkoçak Turan I, Erdem D, Mutlu NM, Buzğan T, Dinç B, Akıncı E. Güner R, et al. Among authors: aypak a. Turk J Med Sci. 2020 Dec 17;50(8):1801-1809. doi: 10.3906/sag-2006-164. Turk J Med Sci. 2020. PMID: 32682358 Free PMC article.
Comparing ICU admission rates of mild/moderate COVID-19 patients treated with hydroxychloroquine, favipiravir, and hydroxychloroquine plus favipiravir.
Guner R, Hasanoglu I, Kayaaslan B, Aypak A, Akinci E, Bodur H, Eser F, Kaya Kalem A, Kucuksahin O, Ates I, Bastug A, Tezer Tekce Y, Bilgic Z, Gursoy FM, Akca HN, Izdes S, Erdem D, Asfuroglu E, Hezer H, Kilic H, Cıvak M, Aydogan S, Buzgan T. Guner R, et al. Among authors: aypak a. J Infect Public Health. 2021 Mar;14(3):365-370. doi: 10.1016/j.jiph.2020.12.017. Epub 2020 Dec 29. J Infect Public Health. 2021. PMID: 33647553 Free PMC article.
Tocilizumab treatment in severe COVID-19: a multicenter retrospective study with matched controls.
Mert A, Vahaboğlu H, Arslan F, Batirel A, Saraçoğlu KT, Bastug A, Çağatay A, Irmak İ, Dizman GT, Ertenli İ, Altunal LN, Sengel BE, Bayram M, Omma A, Amikishiyev S, Aypak A, Bes C, Bolukçu S, Içten S, Topeli A, Bektaş M, Arslan BY, Öztürk S, Çomoğlu Ş, Aydin S, Küçükşahin O, Içaçan OC, Ince B, Aghamuradov S, Mutlu MY, Şimşek F, Emre S, Ustun C, Ergen P, Aydin Ö, Koç MM, Sevindik ÖG, Odabaşı Z, Korten V, Bodur H, Güner R, Ünal S, Kocak M, Gül A. Mert A, et al. Among authors: aypak a. Rheumatol Int. 2022 Mar;42(3):457-467. doi: 10.1007/s00296-021-04965-6. Epub 2021 Sep 13. Rheumatol Int. 2022. PMID: 34515808 Free PMC article.
26 results